Papers - TAKAHATA Takenori
-
Weekly paclitaxel and nedaplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a phase I/II study
Yukihiro Hasegawa, Shingo Takanashi,Takenori Takahata et al
Japanese Journal of Clinical Oncology 34 647 - 653 2004.4
-
Phase I study of 24-hr continuous hepatic arterial infusion of irinotecan (24hr HAI CPT-11) for patients with hepatocellular carcinoma (HCC)
Koji Suto, Yuh Sakata, Takenori Takahata et al
Annals of Oncology 15 106 2004.4
-
Liquid chromatographic determination of fexofenadine in human plasma with fluorescence detection
Tsukasa Uno, Norio Yasui-Furukori, Takenori Takahata et al
Journal of Pharmaceutical Biomedical Analysis 35 937 - 942 2004.4
-
Effect of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes
Norio Yasui-Furukori, Masato Saito, Takenori Takahata et al
Journal of Clinical Pharmacology 44 1223 - 1229 2004.4
-
Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes
Norio Yasui-Furukori, Kazuo Mihara, Takenori Takahata et al
British Journal of Clinical Pharmacology 57 569 - 575 2004.4
-
Fexofenadine does not affect omeprazple pharmacokinetics: both are putative P-glycoprotein substrates
Takenori Takahata et al
Basic and Clinical Pharmacology and Toxicology 94 252 - 256 2004.4
-
Inhibition of 3T3-L1 adipocyte differentiation by 6-ethoxyzolamide: repressed peroxysome proliferator-activated receptor gamma mRNA and enhanced CCAAT/enhancer binding protein beta mRNA levels
Takenori Takahata et al
Biochemical Pharmacology 67 1667 - 1675 2004.4
-
Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes.
Yasui-Furukori N, Takahata T, Nakagami T, Yoshiya G, Inoue Y, Kaneko S, Tateishi T
British journal of clinical pharmacology 57 ( 4 ) 487 - 94 2004.4
-
CYP2C19遺伝子型別にみたオメプラゾールの代謝に与えるフルボキサミンの影響
古郡 規雄, 高畑 武功, 中神 卓, 兼子 直, 立石 智則
臨床薬理 35 ( 1 ) 223S - 223S 2004
-
Lansoprazoleの薬物相互作用とCYP2C19遺伝子多型の関連性の検討
齋藤 正人, 古郡 規雄, 宇野 司, 高畑 武功, 菅原 和信, 棟方 昭博, 立石 智則
臨床薬理 35 ( 1 ) 222S - 222S 2004
-
健康成人を対照とした肝硬変患者における塩酸ランジオロール臨床薬理試験
高畑 武功, 古郡 規雄, 立石 智則, 須藤 晃司, 須藤 俊之, 棟方 昭博
臨床薬理 35 ( 1 ) 191S - 191S 2004
-
Nucleotide changes in the translated region of SCN5A from Japanese patients with Brugada syndrome and control subjects.
Takahata T, Yasui-Furukori N, Sasaki S, Igarashi T, Okumura K, Munakata A, Tateishi T
Life sciences 72 ( 21 ) 2391 - 9 2003.4
-
CYP2C19 mutation frequency in elderly subjects living in a sparsely populated area of Shimokita peninsula (jointly worked)
Yukio Ishizawa, Takenori Takahata et al
Hirosaki Medical Journal 55 18 - 22 2003.4
-
Time effects of food intake on the pharmacokinetics and pharmacodynamics of quazepam
N Yasui-Furukori, T Takahata, T Kondo, K Mihara, S Kaneko, T Tateishi
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 55 ( 4 ) 382 - 388 2003.4
-
CYP2C19 mutation frequency in elderly subjects living in a sparsely populated area of Shimokita peninsula
Ishizawa Yukio, Takahata Takenori, Yasui-Furukori Norio, Saito Masato, Sasaki Mutsuo, Tateishi Tomonori
Hirosaki Medical Journal 55 ( 1 ) 18 - 22 2003
-
クアゼパムの吸収過程における食事摂取時間と食事中の脂肪量の影響について
古郡 規雄, 高畑 武功, 近藤 毅, 三原 一雄, 小野 真吾, 兼子 直, 立石 智則
臨床薬理 34 ( 2 ) 293S - 294S 2003
-
Effect of dietary fat content in meals on pharmacokinetics of quazepam.
Yasui-Furukori N, Kondo T, Takahata T, Mihara K, Ono S, Kaneko S, Tateishi T
Journal of clinical pharmacology 42 ( 12 ) 1335 - 40 2002.12
-
Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection
N Yasui-Furukori, R Furuya, T Takahata, T Tateishi
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 768 ( 2 ) 261 - 265 2002.3
-
Ｃａｒｂａｍａｚｅｐｉｎｅ併用によってＮｉｌｖａｄｉｐｉｎｅの降圧効果の減弱をみた症例
古郡 規雄, 高畑 武功, 立石 智則
臨床薬理 33 ( 1 ) 143S - 144S 2002
-
Metabolism of glucocorticoid hormone by macrophage migration inhibitory factor
M Hayakari, J Kimura, T Kumano, T Takahata, S Suzuki, K Satoh, S Tsuchida
NEW DIRECTIONS FOR CELLULAR AND ORGAN TRANSPLANTATION 1210 31 - 35 2000